[Federal Register Volume 85, Number 51 (Monday, March 16, 2020)]
[Notices]
[Page 14883]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-05315]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-16-2020]


Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification 
of Proposed Production Activity; Zoetis, LLC (Pharmaceutical Products), 
Kalamazoo, Michigan

    Zoetis, LLC (Zoetis) submitted a notification of proposed 
production activity to the FTZ Board for its facility in Kalamazoo, 
Michigan. The notification conforming to the requirements of the 
regulations of the FTZ Board (15 CFR 400.22) was received on March 9, 
2020.
    Zoetis' facility is located within FTZ 43. The facility is used for 
the production of pharmaceuticals for the animal pharmaceutical 
industry. Pursuant to 15 CFR 400.14(b), FTZ activity would be limited 
to the specific foreign-status materials and components and specific 
finished products described in the submitted notification (as described 
below) and subsequently authorized by the FTZ Board.
    Production under FTZ procedures could exempt Zoetis from customs 
duty payments on the foreign-status components used in export 
production. On its domestic sales, for the foreign-status materials/
components noted below, Zoetis would be able to choose the duty rates 
during customs entry procedures that apply to: Apoquel[supreg] (atopic 
dermatitis); Stronghold[supreg] Plus (antiparasitic); Revolution Plus 
[supreg] (antiparasitic); Versatrine[supreg] Pron (ectoparasiticide); 
Spot on Pron (ectoparasiticide); Coopers Spot on Pron 
(ectoparasiticide); Alphamax Conc Sol (parasiticide) and, Simparica 
TrioTM (antiparasitic) (duty rate ranges from duty-free to 
6.5%). Zoetis would be able to avoid duty on foreign-status components 
which become scrap/waste. Customs duties also could possibly be 
deferred or reduced on foreign-status production equipment.
    The components and materials sourced from abroad include: 
Oclacitinib maleate; saroloner; deltamethrin 1% solution; and, 
deltamethrin concentrate 10MG/ML (duty rate 6.5%). The request 
indicates that certain materials/components are subject to special 
duties Section 301 of the Trade Act of 1974 (Section 301), depending on 
the country of origin. The applicable Section 301 decisions require 
subject merchandise to be admitted to FTZs in privileged foreign status 
(19 CFR 146.41).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is April 27, 2020.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected] or (202) 482-1963.

    Dated: March 10, 2020.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2020-05315 Filed 3-13-20; 8:45 am]
 BILLING CODE 3510-DS-P